Research Support Core A: Computational Modeling of Mammalian Biomolecular
研究支持核心 A:哺乳动物生物分子的计算模型
基本信息
- 批准号:9257391
- 负责人:
- 金额:$ 44.15万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:
- 资助国家:美国
- 起止时间:至
- 项目状态:未结题
- 来源:
- 关键词:AHR geneAgonistAntibodiesAntigensAryl Hydrocarbon ReceptorB cell differentiationB-Cell ActivationB-LymphocytesBioenergeticsBiologicalBiological ProcessCD40 LigandChemicalsCholineCommunitiesComplexComputer SimulationDevelopmentDevelopmental ProcessDioxinsDoseEducationEmbryoEndocrineEnvironmental PollutionExposure toFatty LiverFundingGene ExpressionGenesGeneticGenetic PolymorphismGenetic TranscriptionGoalsGrantHealthHealth SciencesHepaticHepatotoxicityHomeostasisHumanImmuneImmunosuppressionImpairmentIndividualInfluentialsInstitutesInterdisciplinary StudyInvestigationKineticsLaboratoriesLaboratory StudyLigandsLinkLiverMetabolismMichiganMitochondriaModelingMouse StrainsMusOocytesOrganOutcomePathway interactionsPhysiologicalPlasma CellsPlayPopulationPregnancyProcessProductionProgram Research Project GrantsPublishingReportingResearchResearch PersonnelResearch Project GrantsResearch Project SummariesResearch SupportRiskRisk AssessmentRoleScientistShapesSignal PathwaySignal TransductionSignal Transduction PathwayStrategic PlanningStructureSuperfundSystems BiologyTimeTissuesToxic effectToxicity TestsToxicologyTrainingUnited States Environmental Protection AgencyUnited States National Academy of SciencesUniversitiesaryl hydrocarbon receptor ligandbasebiological systemscollaborative approachcomputational toxicologycomputerized toolscytokinedesigndifferentiated B cellexperimental studyimmunotoxicityimplantationimprovedlipid metabolismlipid transportmathematical modelmicrobialnatural Blastocyst Implantationpharmacokinetic modelplasma cell differentiationprogramsresponsesuccess
项目摘要
PROJECT SUMMARY (See instructions): The Research Support Core A (Computational Core) will develop mathematical models of toxicity pathways perturbed by the environmental contaminant 2,3,7,8-tetrachlorodiobenzo-p-dioxin (TCDD) and related compounds acting via the aryl hydrocarbon receptor (AhR) in support of Research Projects 1, 2, 3, and 4. The proposed models will be structured at a level of detail appropriate to the toxicological endpoints being pursued in the Projects, including immunotoxicity, embryotoxicity and bioenergetic disruption. Representing working hypotheses about the functions of the biological systems being studied and their perturbation by AhR ligands, these models will contain components and interactions that are experimentally well-validated as well as more tentative ones that are the focus of the proposed collaborative research. The potential of multidisciplinary collaborations is exemplified by our success in the last funding period, where coordinated modeling and experimental research has led to much improved understanding of how TCDD suppresses B lymphocyte differentiation through interfering with a bistable gene network and how stochastic gene expression influences the shape of dose response curves. None of these findings could have been made by laboratory experimentation or computational modeling alone. An essential feature of the current proposal is to continue this approach of coordinating laboratory studies with development of computational models, only more extensively. Specific Aim 1 will implement a model of key regulatory motifs for the activation of primary human B cells by multiple cytokines and antigens, and the disruption of the activation processes by TCDD (in supporting Projects 1 and 2). Under Specific Aim 2 a multi-organ model of bioenergetics will be developed, with the goal of better understanding how TCDD perturbs hepatic energy homeostasis, leading to fatty liver, alteration of choline metabolism, and disruption of mitochondrial function (in supporting Projects 3 and 4). Under Specific Aim 3 we will support Project 2 by developing a computational model of early mouse pregnancy to investigate the mechanism by which TCDD suppresses embryonic implantation and study dose responses. Finally, in coordination with the Training Core, Specific Aim 4 will offer computational toxicology courses to Research Project trainees and investigators and the general Superfund Research community.
项目摘要(见说明):研究支持核心A(计算核心)将开发由环境污染物2,3,7,8-四氯二苯并-p-二恶英(TCDD)和相关化合物通过芳烃受体(AhR)作用干扰的毒性途径的数学模型,以支持研究项目1,2,3和4。拟议模型的结构将以适合项目中追求的毒理学终点的详细程度进行,包括免疫毒性、胚胎毒性和生物能量破坏。这些模型代表正在研究的生物系统的功能及其受AhR配体干扰的工作假设,将包含实验验证良好的组件和相互作用,以及拟议的合作研究的重点是更试探性的。多学科合作的潜力体现在我们的成功,在最后一个资助期,协调的建模和实验研究已经导致了很大程度上提高了对TCDD如何抑制B淋巴细胞分化,通过干扰一个转录因子基因网络和随机基因表达如何影响剂量反应曲线的形状的理解。这些发现都不可能仅仅通过实验室实验或计算模型来实现。目前建议的一个基本特点是继续这种协调实验室研究与计算模型开发的方法,只是更广泛。具体目标1将实施一个关键调节基序模型,用于通过多种细胞因子和抗原激活原代人类B细胞,并通过TCDD破坏激活过程(支持项目1和2)。在具体目标2下,将开发生物能量学的多器官模型,目的是更好地了解四氯二苯并对二恶英如何扰乱肝脏能量稳态,导致脂肪肝、胆碱代谢改变和线粒体功能破坏(支持项目3和4)。在具体目标3下,我们将通过开发小鼠早期妊娠的计算模型来支持项目2,以研究TCDD抑制胚胎植入的机制并研究剂量反应。最后,与培训核心协调,具体目标4将提供计算毒理学课程,研究项目的学员和调查人员和一般的超级基金研究社区。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Rory Clement Bards Conolly其他文献
Rory Clement Bards Conolly的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Rory Clement Bards Conolly', 18)}}的其他基金
Core--Computational Modeling of Mammalian Biomolecular R
核心--哺乳动物生物分子R的计算模型
- 批准号:
7064118 - 财政年份:2006
- 资助金额:
$ 44.15万 - 项目类别:
Research Support Core A: Computational Modeling of Mammalian Biomolecular
研究支持核心 A:哺乳动物生物分子的计算模型
- 批准号:
8898985 - 财政年份:
- 资助金额:
$ 44.15万 - 项目类别:
Core--Computational Modeling of Mammalian Biomolecular Responses
核心——哺乳动物生物分子反应的计算模型
- 批准号:
7599131 - 财政年份:
- 资助金额:
$ 44.15万 - 项目类别:
Core--Computational Modeling of Mammalian Biomolecular Responses
核心——哺乳动物生物分子反应的计算模型
- 批准号:
8055599 - 财政年份:
- 资助金额:
$ 44.15万 - 项目类别:
Core--Computational Modeling of Mammalian Biomolecular Responses
核心——哺乳动物生物分子反应的计算模型
- 批准号:
7792425 - 财政年份:
- 资助金额:
$ 44.15万 - 项目类别:
Research Support Core A: Computational Modeling of Mammalian Biomolecular
研究支持核心 A:哺乳动物生物分子的计算模型
- 批准号:
8564249 - 财政年份:
- 资助金额:
$ 44.15万 - 项目类别:
Research Support Core A: Computational Modeling of Mammalian Biomolecular
研究支持核心 A:哺乳动物生物分子的计算模型
- 批准号:
8695358 - 财政年份:
- 资助金额:
$ 44.15万 - 项目类别:
Core--Computational Modeling of Mammalian Biomolecular Responses
核心——哺乳动物生物分子反应的计算模型
- 批准号:
7466406 - 财政年份:
- 资助金额:
$ 44.15万 - 项目类别:
相似国自然基金
Agonist-GPR119-Gs复合物的结构生物学研究
- 批准号:32000851
- 批准年份:2020
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
相似海外基金
S1PR1 agonistによる脳血液関門制御を介した脳梗塞の新規治療法開発
S1PR1激动剂调节血脑屏障治疗脑梗塞新方法的开发
- 批准号:
24K12256 - 财政年份:2024
- 资助金额:
$ 44.15万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
AHR agonistによるSLE皮疹の新たな治療薬の開発
使用 AHR 激动剂开发治疗 SLE 皮疹的新疗法
- 批准号:
24K19176 - 财政年份:2024
- 资助金额:
$ 44.15万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Evaluation of a specific LXR/PPAR agonist for treatment of Alzheimer's disease
特定 LXR/PPAR 激动剂治疗阿尔茨海默病的评估
- 批准号:
10578068 - 财政年份:2023
- 资助金额:
$ 44.15万 - 项目类别:
AUGMENTING THE QUALITY AND DURATION OF THE IMMUNE RESPONSE WITH A NOVEL TLR2 AGONIST-ALUMINUM COMBINATION ADJUVANT
使用新型 TLR2 激动剂-铝组合佐剂增强免疫反应的质量和持续时间
- 批准号:
10933287 - 财政年份:2023
- 资助金额:
$ 44.15万 - 项目类别:
Targeting breast cancer microenvironment with small molecule agonist of relaxin receptor
用松弛素受体小分子激动剂靶向乳腺癌微环境
- 批准号:
10650593 - 财政年份:2023
- 资助金额:
$ 44.15万 - 项目类别:
AMPKa agonist in attenuating CPT1A inhibition and alcoholic chronic pancreatitis
AMPKa 激动剂减轻 CPT1A 抑制和酒精性慢性胰腺炎
- 批准号:
10649275 - 财政年份:2023
- 资助金额:
$ 44.15万 - 项目类别:
Investigating mechanisms underpinning outcomes in people on opioid agonist treatment for OUD: Disentangling sleep and circadian rhythm influences on craving and emotion regulation
研究阿片类激动剂治疗 OUD 患者结果的机制:解开睡眠和昼夜节律对渴望和情绪调节的影响
- 批准号:
10784209 - 财政年份:2023
- 资助金额:
$ 44.15万 - 项目类别:
A randomized double-blind placebo controlled Phase 1 SAD study in male and female healthy volunteers to assess safety, pharmacokinetics, and transient biomarker changes by the ABCA1 agonist CS6253
在男性和女性健康志愿者中进行的一项随机双盲安慰剂对照 1 期 SAD 研究,旨在评估 ABCA1 激动剂 CS6253 的安全性、药代动力学和短暂生物标志物变化
- 批准号:
10734158 - 财政年份:2023
- 资助金额:
$ 44.15万 - 项目类别:
A novel nanobody-based agonist-redirected checkpoint (ARC) molecule, aPD1-Fc-OX40L, for cancer immunotherapy
一种基于纳米抗体的新型激动剂重定向检查点 (ARC) 分子 aPD1-Fc-OX40L,用于癌症免疫治疗
- 批准号:
10580259 - 财政年份:2023
- 资助金额:
$ 44.15万 - 项目类别:
Identification and characterization of a plant growth promoter from wild plants: is this a novel plant hormone agonist?
野生植物中植物生长促进剂的鉴定和表征:这是一种新型植物激素激动剂吗?
- 批准号:
23K05057 - 财政年份:2023
- 资助金额:
$ 44.15万 - 项目类别:
Grant-in-Aid for Scientific Research (C)














{{item.name}}会员




